coumaglutide

has hypoglycemic activity; structure in first source

Also Known As:

Gly(8),Cys(17)-(3-(12-(N-(4-((4-hydroxy-2-oxo-2H-chromen-3-yl)(4-hydroxy-2-oxochroman-3-yl)methyl)phenyl)carbamoymethyl)dodecyl)succinimidyl)-GLP-1(7-36)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        coumaglutide: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        coumaglutide: 1
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gastrointestinal Hormones: 573
    - Proglucagon: 128
      - Glucagon-Like Peptides: 424
        Glucagon-Like Peptide 1: 6089
        coumaglutide: 1

Experts

1.	Cai, Xingguang: 1 article (11/2015)
2.	Chu, Yingying: 1 article (11/2015)
3.	Dai, Yuxuan: 1 article (11/2015)
4.	Han, Jing: 1 article (11/2015)
5.	Huang, Wenlong: 1 article (11/2015)
6.	Qian, Hai: 1 article (11/2015)
7.	Sun, Lidan: 1 article (11/2015)
8.	Wang, Chuandong: 1 article (11/2015)
9.	Zhou, Jie: 1 article (11/2015)

Related Diseases

1.	Body Weight (Weight, Body) 11/15/2015 - "Moreover, STZ-induced diabetic mice were treated daily with coumaglutide for 20 days and a range of pharmacologic parameters, including hemoglobin A1c (HbA1C), intraperitoneal glucose tolerance, food intake and body weight were assessed before and after the treatment. "

Related Drugs and Biologics

1.	Hemoglobins (Hemoglobin)
2.	Glucose (Dextrose)